BamSEC and AlphaSense Join Forces
Learn More

Pacira BioSciences Inc.

NASDAQ: PCRX    
Share price (1/3/25): $18.40    
Market cap (1/3/25): $850 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 8-K 110 pages Pacira Biosciences, Inc. and Computershare Trust Company, National Association, as Trustee Indenture Dated as of May 14, 2024 2.125% Convertible Senior Notes Due 2029
12/34/56
EX-4.1
from 10-K 2 pages Specimen Certificate Evidencing Shares of Common Stock Pacira Biosciences, Inc
12/34/56
EX-4.5
from 10-K 4 pages Flexion Therapeutics, Inc. and Wells Fargo Bank, National Association, as Trustee First Supplemental Indenture Dated as of November 19, 2021 3.375% Convertible Senior Notes Due 2024
12/34/56
EX-4.4
from 10-K 111 pages Flexion Therapeutics, Inc. and Wells Fargo Bank, National Association, as Trustee Indenture Dated as of May 2, 2017 3.375% Convertible Senior Notes Due 2024
12/34/56
EX-4.1
from 8-K 107 pages Pacira Biosciences, Inc. and Wells Fargo Bank, National Association, as Trustee Indenture Dated as of July 10, 2020 0.750% Convertible Senior Notes Due 2025
12/34/56
EX-4.3
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 10-Q 2 pages Specimen Certificate Evidencing Shares of Common Stock Pacira Biosciences, Inc
12/34/56
EX-4.1
from 8-K 108 pages Pacira Pharmaceuticals, Inc. and Wells Fargo Bank, National Association, as Trustee Indenture Dated as of March 13, 2017 2.375% Convertible Senior Notes Due 2022
12/34/56
EX-4.4
from S-3ASR 8 pages Form of Subordinated Note
12/34/56
EX-4.3
from S-3ASR 8 pages Form of Senior Note
12/34/56
EX-4.2
from S-3ASR 54 pages Pacira Pharmaceuticals, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.1
from S-3ASR 51 pages Pacira Pharmaceuticals, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.1
from 8-K 102 pages Pacira Pharmaceuticals, Inc. and Wells Fargo Bank, National Association, as Trustee Indenture Dated as of January 23, 2013 3.25% Convertible Senior Notes Due 2019
12/34/56
EX-4.4
from S-3 8 pages Form of Subordinated Note
12/34/56
EX-4.3
from S-3 8 pages Form of Senior Note
12/34/56
EX-4.2
from S-3 55 pages Pacira Pharmaceuticals, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.1
from S-3 51 pages Pacira Pharmaceuticals, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.1
from S-1/A 2 pages Specimen Certificate Evidencing Shares of Common Stock
12/34/56